|
Delayed
Nyse
-
04:00 2022-07-01 pm EDT
|
97.39 |
USD
|
|
+2.42%
|
|
|
|
06/15 | INSIDER SELL : Edwards Lifesciences | MT |
06/09 | Corvia Medical, Inc. announced that it has received $54 million in funding from Accelmed Partners, Lumira Ventures, General Catalyst Group Management, LLC, Third Rock Ventures, LLC, Edwards Lifesciences Corporation, and other investors | CI |
06/09 | Corvia Medical, Inc. announced that it has received $54 million funding from General Catalyst Group Management, LLC, Edwards Lifesciences Corporation, Lumira Ventures, Third Rock Ventures, LLC, Accelmed Partners | CI |
|
|
Insider Sell: Edwards Lifesciences
© MT Newswires 2022
All news about EDWARDS LIFESCIENCES CORPORATION |
|
|
|
Analyst Recommendations on EDWARDS LIFESCIENCES CORPORATION |
|
|
| |
|
Sales 2022 |
5 737 M
-
-
|
Net income 2022 |
1 573 M
-
-
|
Net cash 2022 |
1 336 M
-
-
|
P/E ratio 2022 |
39,0x |
Yield 2022 |
- |
|
Capitalization |
60 552 M
60 552 M
-
|
EV / Sales 2022 |
10,3x |
EV / Sales 2023 |
9,05x |
Nbr of Employees |
15 700 |
Free-Float |
95,9% |
|
Chart EDWARDS LIFESCIENCES CORPORATION |
|
Duration :
Period :
|
 |
|
Technical analysis trends EDWARDS LIFESCIENCES CORPORATION
| Short Term | Mid-Term | Long Term | Trends | Neutral | Bearish | Bearish |
Income Statement Evolution
|
Mean consensus |
BUY |
Number of Analysts |
23 |
Last Close Price |
97,39 $ |
Average target price |
124,33 $ |
Spread / Average Target |
27,7% |
|
|
|
|